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Abstract
Background—Patients with congenital heart disease (CHD) and heterotaxy show high
postsurgical morbidity/mortality, with some developing respiratory complications. Although this
finding is often attributed to the CHD, airway clearance and left-right patterning both require
motile cilia function. Thus, airway ciliary dysfunction (CD) similar to that of primary ciliary
dyskinesia (PCD) may contribute to increased respiratory complications in heterotaxy patients.
Methods and Results—We assessed 43 CHD patients with heterotaxy for airway CD.
Videomicrocopy was used to examine ciliary motion in nasal tissue, and nasal nitric oxide (nNO)
was measured; nNO level is typically low with PCD. Eighteen patients exhibited CD characterized
by abnormal ciliary motion and nNO levels below or near the PCD cutoff values. Patients with CD
aged >6 years show increased respiratory symptoms similar to those seen in PCD. Sequencing of
all 14 known PCD genes in 13 heterotaxy patients with CD, 12 without CD, 10 PCD disease
controls, and 13 healthy controls yielded 0.769, 0.417, 1.0, and 0.077 novel variants per patient,
respectively. One heterotaxy patient with CD had the PCD causing DNAI1 founder mutation.
Another with hyperkinetic ciliary beat had 2 mutations in DNAH11, the only PCD gene known to
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cause hyperkinetic beat. Among PCD patients, 2 had known PCD causing CCDC39 and CCDC40
mutations.
Conclusions—Our studies show that CHD patients with heterotaxy have substantial risk for CD
and increased respiratory disease. Heterotaxy patients with CD were enriched for mutations in
PCD genes. Future studies are needed to assess the potential benefit of prescreening and
prophylactically treating heterotaxy patients for CD.
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Heterotaxy is characterized by randomized variation in the patterning of left-right
asymmetry of visceral organs in the thoracic and abdominal cavities. Because left-right
asymmetries in the cardiovascular system are essential for efficient oxygenation of blood,
heterotaxy patients often need complex cardiac surgeries to repair their structural heart
defects. Such cardiac surgeries in heterotaxy patients are associated with disproportionately
higher postoperative morbidity and mortality,1 often with prolonged clinical courses
associated with respiratory and multiple serious complications.2 A retrospective review of
96 patients with congenital heart disease (CHD) operated on at Children’s Hospital in
Boston showed that 11 of 16 patients dying during the 1-month follow-up period were
heterotaxy patients.3 Another study analyzing surgical outcomes showed 4.8% postoperative
mortality for CHD patients with heterotaxy versus 2.4% for CHD patients without
heterotaxy.4 Our retrospective study of CHD patients undergoing cardiac surgery at
Children’s National Medical Center showed that 84 heterotaxy patients had greater
postsurgical mortality, increased postsurgical respiratory complications, and more
complicated postsurgical course in comparison with 634 CHD patients without heterotaxy
undergoing surgeries with comparable Risk Adjustment in Congenital Heart Surgery-1
scores.5 These findings suggest that heterotaxy patients have unexplained worse outcomes,
with our study indicating an association with increased respiratory complications.
Respiratory complications in patients with CHD are generally attributed to the heart disease,
but because airway clearance and left-right patterning both require motile cilia function, it is
possible that defects in motile cilia function in the respiratory epithelia could be a
contributing factor. The cilium is a complex highly conserved microtubule-based organelle
comprising >500 proteins.6 Cilia are found from single-cell organisms such as
Chlamydomonas to humans and can be nonmotile or motile.7 Motile cilia play an important
role in mucociliary clearance via coordinated waves of ciliary motion that sweep mucus out
of the airway, allowing the removal of cellular debris, microbial contaminants, and other
foreign matter. Patients with primary ciliary dyskinesia (PCD) have ineffective mucociliary
clearance because of immotile cilia or abnormal ciliary motion.8 Consequently, PCD
patients often exhibit newborn respiratory distress and develop sinopulmonary disease,
including bronchiectasis. Because motile cilia in the embryonic node also play a critical role
in generating nodal flow required for establishing the left-right body axis and patterning of
visceral organ situs,9 approximately half of PCD patients show complete mirror reversal of
visceral organ situs (situs inversus totalis).10
Studies in mice showed that mutation in Dnahc5, a gene known to cause PCD, can result in
a high prevalence of complex CHD and heterotaxy.11 This mutant is a bona fide model of
PCD, exhibiting immotile or dyskinetic respiratory cilia and missing outer dynein arm
ultrastructural defect.12 Whereas 60% of Dnahc5 mutants are postnatal viable with situs
solitus or situs inversus totalis with no heart disease, 40% are prenatal/neonatal lethal with
heterotaxy and complex CHD. A retrospective clinical study confirmed a link between PCD
and heterotaxy with the finding of 6% incidence of heterotaxy among >300 PCD patients
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examined, with 1 of 3 of the heterotaxy patients also exhibiting CHD.13 Because PCD and
heterotaxy are both rare disorders with a prevalence estimated at 1 in 15 000 to 20 000, these
findings suggest a mechanistic link between PCD and heterotaxy/CHD.
To investigate whether CHD patients with heterotaxy may have ciliary dysfunction (CD)
similar to that of PCD, in this study we assessed airway ciliary function in CHD patients
with heterotaxy and used next-generation sequencing to scan for mutations in all 14 genes
known to cause PCD. Our studies indicate that heterotaxy patients have significant risk for
CD, and this may involve PCD and other cilia genes not known to cause PCD.
Methods
Patient Recruitment
Participants with CHD and heterotaxy were recruited from Children’s National Medical
Center, National Institutes of Health, University of Pittsburgh, and University of North
Carolina with the use of study protocols approved by the respective institutional review
boards. Informed consent was obtained from adult subjects or parent of children, with assent
also obtained for children >7 years of age. Medical and family history was obtained by use
of information from a questionnaire and medical chart review. Blood and/or saliva samples
were obtained for genetic analysis. Cardiothoracoabdominal organ situs was assessed by
using data obtained by echocardiography, catheterization, and chest and abdominal
radiographs and sonographs (see online-only Data Supplement Tables I and II). Cardiac
situs was delineated by use of Van Praagh segmental classification.14
Nasal Nitric Oxide Measurements
Nasal NO (nNO) measurements were made with use of a chemiluminescence nitric oxide
analyzer (CLD88 SP, ECOPHYSICS AG) with established protocols15 (see online-only
Data Supplement Methods and online-only Data Supplement Figure II). For participants >6
years of age, measurements were made by use of the velum-closure technique according to
American Thoracic Society/European Respiratory Society guidelines. In patients <6 years of
age, NO measurements were made with tidal breath sampling.16 Some patients with CD and
low nNO were reevaluated with a sweat chloride test to exclude cystic fibrosis (online-only
Data Supplement Table I).
Nasal Tissue Sampling and Ciliary Motion Analysis
Nasal tissue was collected with use of Rhino-Probe (Arlington Scientific, Springville, UT)
curettage of the inferior nasal turbinate. Exclusion criteria included severe bleeding diathesis
or conditions such as hemophilia or hereditary hemorrhagic telangiectasia syndrome. The
nasal tissue was suspended in L-15 medium (Invitrogen, CA) for videomicroscopy using a
Leica inverted microscope (DMIRE2) with a 100× oil objective under differential
interference contrast optics. Movies were recorded at 200 frames/s at room temperature by
use of a Phantom v4.2 camera (Vision Research, NJ), and digital recordings were evaluated
by a blinded panel of coinvestigators (M.L., M.K., R.F., C.W.L., H.O.).
Targeted Sequence Capture and Next-Generation Sequencing
A custom Roche NimbleGen array was designed for targeted capture of coding exons for the
14 PCD genes. Sequence capture and library preparation for SOLiD4 sequencing were
performed by use of standard protocols (http://www.nimblegen.com/products/lit/
SeqCap_UsersGuide_Service_v3p0.pdf). The Agilent SureSelect human all-exon array were
used for sequence analysis of the healthy controls and 9 of the 10 PCD patients. Sequencing
data were processed by use of AB Bioscope, with further analysis using CLC Genomics
Workbench v4.0.3. Single-nucleotide variants and small insertions/deletions (1–10 bp) were
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identified by single-nucleotide polymorphism/deletion-insertion polymorphism detection
program at bases with quality scores >20 (99% accuracy), coverage >5 times, and variant
allele frequency >20%. Novel coding variants (NCVs) were validated by Sanger sequencing.
Statistical Analysis
The Welch t test for unequal variances was used to compare nNO measurements after log
transformation of the data. To control for type I error, we applied Bonferroni correction for
multiple comparisons (CD versus no-CD heterotaxy patients, healthy controls, or PCD
patients; CD-A versus CD-B; no-CD versus healthy control) in each age group, and a
probability value of <0.01 was considered statistically significant. If nNO measurements in
the CD group were statistically significantly different from no-CD, healthy control, or PCD
groups, then we also compared the CD-A and CD-B subgroups with these groups. The χ2
test was used to test for differences in categorical variables. The analysis of the respiratory
symptoms used the Wilcoxon rank-sum test to compare the number of symptoms and the
Fisher exact test to compare the frequency of individual symptoms between the CD and no-
CD patients. For the DNA-sequencing data, we examined the differences in the presence of
NCVs and in the number of NCVs among the 4 groups (heterotaxy patients with CD,
heterotaxy patients without CD, PCD patients, and control subjects) using the Fisher exact
test and the Kruskal-Wallis test, respectively, and a probability value of <0.025 was
considered statistically significant for each test based on the Bonferroni correction. Pairwise
comparisons were performed with use of the Fisher exact test or the Wilcoxon rank-sum test
only if the comparison in NCVs among the 4 groups showed statistically significant
difference. All tests were 2-sided. Analyses were performed with SAS 9.2 (SAS Institute,
Cary, NC).
Results
Forty-eight heterotaxy patients were recruited into our study, with 43 having completed the
entire study protocol. Among the 43 patients, 20 (47%) had cardiovascular situs defects only
(cohort I) and 23 (52%) had cardiovascular and abdominal/lung laterality defects (cohort II)
(Figure 1;Table 1). We defined heterotaxy as abnormal or discordant situs involving the
cardiovascular system with or without lung or abdominal situs abnormalities (see online-
only Data Supplement Methods). This broad definition is based on the known requirement
for motile cilia function in left-right patterning of visceral organs in the body. Many of the
structural heart defects typically associated with heterotaxy were observed in our patients
(Figure 1; online-only Data Supplement Table I).11,17 Thoracic laterality defects and other
disorders were also recorded (see online-only Data Supplement Table II). Patients were
further grouped as perioperative for those hospitalized for surgical procedures, or
nonperioperative for patients that are either being seen in the Adult Congenital Heart
Disease Clinic or undergoing in hospital diagnostic evaluation (see online-only Data
Supplement Methods) (Table 1). In addition, we also recruited 18 PCD patients without
CHD as disease controls and 25 healthy subjects as healthy controls (Table 1).
Assessment of Ciliary Motion by Videomicroscopy
Nasal tissue was obtained from each patient and assessed for ciliary motion defects by
videomicroscopy, and subsequently ciliary beat frequency (CBF) was obtained from
analysis of the video sequences (Table 1). Analysis of the CBFs showed no difference in the
heterotaxy patients versus healthy controls (P>0.5) (online-only Data Supplement Figure I).
However, 2 heterotaxy patients had exceptionally high CBF of 16 Hz (patient 9003) and
19.7 Hz (patient 9002) (Table 1). To assess for other abnormalities in ciliary motion, we
examined the pattern of ciliary beat by using slow-motion play back of the video sequence
to generate tracings of the ciliary beat (Figure 2). In normal nasal epithelia, the ciliary beat
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pattern is characterized by metachronal waves composed of forward and reverse strokes
sweeping in a planar motion synchronously across the respiratory epithelium (Figure 2D;
online-only Data Supplement Movie I).18 In PCD patients, a wide range of ciliary motion
defects was observed, including immotility, stiff/dyskinetic ciliary motion, and other motion
defects (online-only Data Supplement Movie II for PCD patient 9028; online-only Data
Supplement Table VI).
Many of the heterotaxy patients also exhibited aberrant ciliary motion (Table 1; online-only
Data Supplement Movies III through VI). This included immotile cilia, cilia with stiff/
dyskinetic beat (online-only Data Supplement Movie III), incomplete stroke (ciliary beat
with decreased amplitude) (online-only Data Supplement Movie IV and Figure 2E), wavy
stroke (online-only Data Supplement Movie V; Figure 2F), or asynchronous beat (online-
only Data Supplement Movie VI). These ciliary motion defects were found in varying
combinations in 18 of the 43 heterotaxy patients (Table 1). In contrast, none of the healthy
controls exhibited ciliary motion abnormalities. In heterotaxy patients 9037 and 9002, cilia
with abnormal motion were observed in a landscape of mostly immotile cilia, similar to
some PCD patients. In heterotaxy patients 9027 and 9046, there was a paucity of cilia
(Figure 2B). For patient 9027, the nasal biopsy was performed twice, and in both instances,
we found few cilia and ciliary motion was stiff/dyskinetic. In patient 9004, we could find no
cilia, either perioperatively at 5.5 months of age or when resampled nonperioperatively at
1.4 years of age (Figure 2C).
After videomicrosocpy, the nasal tissue samples from heterotaxy and PCD patients were
processed for electron microscopy to examine cilia ultrastructure. Cross-sectional views
suitable for cilia ultrastructure analysis were obtained for 29 of 41 heterotaxy patients,
including 11 with CD (Table 1), but no defects were found. In comparison, electron
microscopy analysis of 9 PCD patients showed 7 with a variety of ultrastructural defects
typically seen with PCD (online-only Data Supplement Table VI).
Assessment of Nasal Nitric Oxide
We measured nasal nNO, which is typically low in PCD patients. Because nNO increased
with age, we grouped the nNO measurements into 3 groups: <1 year of age, 1 to 6 years of
age, and >6 years of age. Newborns exhibit nNO just a few nanoliters per minute at birth. At
1 to 6 years of age, nNO levels rise to >100 nL/min.16 In healthy adults, nNO values are
usually >200 nL/min.19 PCD patients 1 to 6 years of age have nNO values <50 nL/min, and
those >6 years of age have nNO values <100 nL/min.20 For patients <1 year of age, nNO
cutoff values have not been established, given that nNO values are usually low but
dynamically increasing.
For controls, we sampled 25 healthy adults, who exhibited mean nNO of 246±52.2 nL/min
(Table 2), and also 18 adult PCD patients, with mean nNO of 16.5±10.5 nL/min (Table 2).
These measurements are consistent with values previously reported.15,19 Assessment of
nNO levels in the 43 heterotaxy patients revealed all 18 patients with ciliary motion defects
have nNO levels either below or near the PCD cutoff values (Tables 1 and 2; Figure 3). We
noted no difference in NO levels in perioperative versus nonperioperative patients (online-
only Data Supplement Table III). Significantly, heterotaxy patients with CD had nNO
measurements lower than that of healthy controls or heterotaxy patients without CD (no-
CD).
Patients >6 Years of Age (Median 18.5 Years)—Nine patients >6 years of age with
ciliary motion defects had mean nNO of 95.6±44 nL/min, significantly lower than that of
either healthy controls (Table 2; P<0.001) or heterotaxy patients without ciliary motion
defects (no-CD in Table 2; P<0.001). Among the 9 patients with CD, 5 patients had nNO of
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64.2±28.7 nL/min, below the 100- nL/min PCD cutoff value, and are referred to as CD type
A or CD-A (Table 2). Four had nNO of 134.8±19.6 nL/min, just above the PCD cutoff value
and are referred to as CD type B or CD-B (Table 2). The CD-A and CD-B nNO levels were
significantly different from the healthy controls (P<0.001 and P=0.002, respectively),
borderline significant from each other (P=0.02), and significantly different from the PCD
patients (P<=0.001) (Table 2).
Patients 1 to 6 Years (Median 2.5 Year)—Four patients exhibiting ciliary motility
defects in this age group had combined mean nNO of 52.3±12.4 nL/min. One had nNO of
34 nL/min, below the 50-nL/min PCD cutoff value and thus was categorized as CD-A
(Table 2). The other 3 patients with ciliary motion defects exhibited 58.3±3.2 nL/min, just
above the 50-nL/min PCD cutoff and thus were categorized as CD-B (Figure 2). Given the
small sample size, no significant difference was observed in the mean nNO value in CD
(52±12.4 nL/min) versus no-CD (79.8±34.3) (P=0.12), but the CD patient nNO
measurements were significantly different from those of healthy controls (118.5±59.3;
P=0.008) and PCD patients (19.7±13.8; P<0.001) (Table 2). The single CD-A patient, 9004,
was assessed twice, nonperioperatively at 1.4 years of age and perioperatively at 5.5 months
of age (see below). The assessment at 1.4 years of age yielded 34 nL/min nNO, within the
PCD range (Table 1).
Patients <1 Year of Age (Median 8 Months)—Five heterotaxy patients in this age
group with ciliary motion defects had mean nNO of 6.1±2.7 nL/min. This is significantly
lower than the 19.6±8.5 nL/min observed in 10 heterotaxy patients with normal ciliary
motion (no-CD; Table 2) (P=0.005) and indistinguishable from the 7.3±5.7 nL/min observed
in PCD patients (P=0.94; Table 2). These patients are classified as having CD without
further stratification given the lack of PCD cutoff values for this age group. Patient 9004
with 16.5 nL/min nNO was designated as CD-A based on retesting at 1.4 years of age.
Analysis of Laterality Defects, Operative Status, and Sex
The prevalence of CD was greater in the cohort with both cardiovascular and abdominal/
lung laterality defects (57%; cohort II) versus those with cardiovascular laterality defects
only (25%; cohort I) (P<0.05) (Figure 1), but it was not different between the perioperative
versus nonperioperative patients (online-only Data Supplement Table IV). In the group >6
years age, CD (type A and B) was observed in 8 nonperioperative versus 1 perioperative
patient (Table 1). Fifty percent of the CD patients were male, in comparison with only 28%
males among patients with no CD, but this difference was not significant given the small
sample size (P=0.14; online-only Data Supplement Table IV).
Analysis of Respiratory Symptoms
Analysis of the prevalence of respiratory symptoms showed 24 of the 43 (56%) patients
have history of at least 1 chronic respiratory manifestation. This was not significantly
different between the CD versus non-CD cohort with 10 (56%) of the 18 CD versus 14
(56%) of the 25 no-CD patients reporting at least 1 respiratory symptom (P>0.1) (Table 3;
online-only Data Supplement Table V). Comparison of the number of perioperative versus
nonperioperative patients with respiratory symptoms also showed no difference (online-only
Data Supplement Table III). Among the 9 patients >6 years of age with at least 1 respiratory
manifestation, 5 patients with CD had more symptoms in comparison with the 4 no-CD
patients (medians are 4 and 2, respectively; P=0.024). Sequelae associated with PCD
(neonatal respiratory distress, bronchiectasis, or recurrent otitis media) were present in 5 of
the 8 CD patients >6 years of age, but none of the 7 no-CD patients (P=0.026).
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Sequencing Analysis of 14 Known PCD Genes
We used next-generation sequencing with targeted exon capture to interrogate for mutations
in all 325 coding exons and flanking intron sequences of the 14 genes known to cause PCD
(see online-only Data Supplement Methods).21–23 Sequencing analysis was performed for
13 heterotaxy patients with CD, 12 heterotaxy patients without CD, 10 PCD disease
controls, and 13 healthy controls (Table 4). An average sequencing coverage of 42 times
was obtained encompassing 99% to 100% of the bases in 12 of the 14 PCD genes (online-
only Data Supplement Table VII). Over 1000 (n=1012) coding variants were identified in
the 48 individuals, including nonsynonymous single-nucleotide variants, insertions/
deletions, and variants altering splice junctions. Filtering to remove variants in dbSNP
(http://www.ncbi.nlm.nih.gov/projects/SNP/) and 1000Genomes (http://www.
1000genomes.org) databases yielded 42 novel single-nucleotide variants, 34 of which
validated by Sanger sequencing (Table 4, online-only Data Supplement Table VIII).
Four PCD patients were found to have 2 known PCD-causing mutations (online-only Data
Supplement Table VIII). Patient 9028 and 9098 were homozygous for a CCDC39 mutation,
1972delA, recently identified to cause PCD.22 Patient 9028 showed ultrastructural defects
consistent with CCDC39 mutations (online-only Data Supplement Table VI). PCD patients
564 and 1401 were both heterozygous for a known PCD causing CCDC40 mutation
(248delC).23 In patient 1401, a second novel CCDC40 mutation was observed, which was
confirmed to be in trans. Cilia ultrastructural abnormalities expected for CCDC40 mutations
were observed (online-only Data Supplement Table VI). In patient 1174, 2 novel DNAH5
mutations were also found in trans, and, consistent with a role in disease, electron
microscopy analysis showed outer dynein arm defects (online-only Data Supplement Table
VI). Sequencing analysis of the 13 heterotaxy patients with CD revealed 1 individual (9002)
heterozygous for the DNAI1 founder mutation, IVS1+2_3insT, known to cause PCD.24
Another patient (9026) had 3 novel mutations, 2 in DNAH5 and1in DNHA11. Patient 9003
exhibited 2 DNAH11 mutations. This was associated with hyperkinetic ciliary beat, a
phenotype unique to PCD arising from DNAH11 mutations.23
Overall, the highest incidence of NCVs was observed in the PCD patients, 1 NCV/subject
(Figure 4; online-only Data Supplement Table IX), followed by heterotaxy patients with CD
yielding 0.769 NCV/subject, then heterotaxy patients with no-CD with 0.417 NCV/subject
(Figure 4; online-only Data Supplement Table IX). In contrast, the healthy controls had a
single variant, yielding 0.077 NCV/subject. Statistical analysis of the percentage of patients
with NCV and the mean number of NCV per subject showed significant differences for
heterotaxy patients with CD and the PCD patients in comparison with controls (Figure 4;
online-only Data Supplement Table IX). This is not accountable by differences in racial
composition, because Fisher exact test for race-ethnicity between the control subjects versus
heterotaxy patients with CD yielded P=0.33 (Table 4; online-only Data Supplement Table
VIII).
Discussion
We showed that 18 of 43 (42%) of patients with CHD associated with heterotaxy have CD.
The abnormal ciliary motion is similar to that seen with PCD, including dyskinetic, stiff, or
wavy ciliary beat. The latter may be comparable to the whiplike motion reported for some
PCD patients.18 Two patients have hyperkinetic ciliary beat reminiscent of ciliary motion
defects caused by DNAH11 mutations.25 Importantly, all heterotaxy patients with CD also
had nNO levels either below (CD-A) or bordering (CD-B) the PCD cutoff values.
Postsurgical trauma cannot account for the finding of CD, because CD was not correlated
with operative status. The risk for CD was higher in patients with laterality defects involving
both cardiovascular and lung/abdominal organs. These findings suggest CHD patients with
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heterotaxy may have CD overlapping with that of PCD. Because PCD and heterotaxy each
have a prevalence of 1 in 15 000 to 20 000 live births, this is not likely by chance, but it may
reflect the common requirement for motile cilia in mucociliary clearance and left-right
patterning.
Ciliary Dysfunction in Heterotaxy versus PCD Patients
Although we observed that heterotaxy patients with CD have low nNO, their mean nNO
values were higher than those of PCD patients, even among CD-A patients. Heterotaxy
patients with CD also have higher CBFs than PCD patients do. Moreover, none of the 11
heterotaxy patients with CD examined by electron microscopy exhibited cilia ultrastructural
defects. In contrast, a recent study of a large cohort of PCD patients showed 50% have cilia
ultrastructural defects.26 Together, these findings suggest heterotaxy patients with CD may
have a variant form of CD differing from PCD. Nevertheless, studies in mouse models have
shown that mutations in PCD genes (Dnahc5, Dnaic1, Dnahc11) can cause CHD with
heterotaxy.11,27,28 However, these may be underrepresented among heterotaxy patients,
because all Dnahc5 and Dnaic1 mutants with heterotaxy die prenatally or neonatally from
complex CHD. Similarly, Dnahc11 iv/iv mutants exhibit a 40% incidence of CHD
prenatally, but only 5% among term fetus or viable adult animals.28,29
Mutations in PCD Genes
Sequencing analysis of 48 subjects showed heterotaxy, and PCD patients were significantly
enriched for NCVs in PCD genes in comparison with healthy controls. We noted that 4 of
the 10 PCD patients did not have mutations in any of the 14 PCD genes, suggesting
additional novel PCD genes are yet to be identified. One heterotaxy patient with CD had a
DNAI1 founder mutation known to cause PCD, whereas 4 PCD patients (3 unrelated) had 2
known PCD causing CCDC39 or CCDC40 mutations. Because PCD is a recessive disorder,
PCD-causing mutations are expected to be homozygous or compound heterozygous.
Consistent with this, 3 PCD patients were homozygous or compound heterozygous for PCD
causing CCDC39 or CCDC40 mutations. In contrast, no heterotaxy patients had 2 known
PCD mutations.
For 5 heterotaxy patients with CD and 2 PCD patients, only a single heterozygous PCD gene
mutation was observed. This included PCD patient 564 with a known disease-causing
CCDC40 mutation, and heterotaxy patient 9002 with the DNAI1 founder mutation. In
heterotaxy patient 9026, a DNAH5/DNAH11 double-heterozygous mutation was observed.
We hypothesize that PCD or CD in heterotaxy patients may arise from 2 mutations, 1 in
each of 2 different cilia-related genes. This may involve the combined effects of mutations
in PCD genes and other cilia-related genes not associated with PCD. Such multigenic
etiology and genetic heterogeneity may underlie the phenotypic differences in the ciliary
dysfunction seen in heterotaxy versus PCD patients. This genetic model is supported by
studies in Chlamydomonas using stable diploids that has shown noncomplementation of
unlinked genes required for ciliogenesis.30,31
Heterotaxy patient 9003 had 2 DNAH11 mutations, both predicted to be damaging.
Although we could not verify if these mutations were in cis given their >143 kb genomic
distance (and parental DNA were unavailable), the finding of hyperkinetic ciliary beat and
normal cilia ultrastructure is consistent with DNAH11 mutations. This patient also exhibited
sequelae consistent with PCD (newborn respiratory distress, otitis media, recurrent
pneumonia, and bronchiectasis). Although this patient had normal cardiac situs, this was
associated with abnormal ipsilateral positioning of the aorta, left-sided IVC, and
polysplenia. This compares favorably with the finding that 95% of viable Dnah11 iv/iv adult
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and newborn mice have atrial situs solitus or atrial situs inversus, but mostly without cardiac
lesions and with 1 of 3 exhibiting abnormal spleens.29
Respiratory Diseases in Heterotaxy Patients With Ciliary Dysfunction
Respiratory symptoms and disease were increased in heterotaxy patients with CD >6 years
of age. Neonatal respiratory distress and bronchiectasis, respiratory complications
commonly associated with PCD, were found only in heterotaxy patients with CD. Although
we did not find a significant increase in respiratory symptoms and disease in heterotaxy
patients with CD from the younger age groups, most of these patients were hospitalized for
cardiac surgery, and their respiratory symptoms are likely largely attributed to their heart
disease. Moreover, respiratory illnesses, such as bronchiectasis, would not manifest until
later in life.
We note CD in the respiratory epithelia also has been reported in patients with Leber
congenital amaurosis (LCA),32 a ciliopathy involving cone-rod dystrophy due to defects in
the connecting cilium required for photoreceptor biogenesis. Patients exhibit “rarefaction of
ciliated cells,” which also was observed in many of our heterotaxy patients with CD.
Analysis of the LCA patient nasal tissue showed abnormal ciliary beat pattern, and 6 of 7
LCA patients had a clinical history of recurrent inflammatory diseases of the airways. These
findings suggest CD and increased respiratory disease may have relevance for other cilia-
related disorders.
Future Prospects
Overall, our studies suggest CHD patients with heterotaxy have substantial risk for CD and
respiratory disease. This may involve mutations in novel and known PCD genes. These
findings suggest CHD patients with heterotaxy may benefit from preoperative screening for
CD. Further studies are needed to evaluate whether therapies enhancing mucus clearance
may reduce respiratory complications and improve postsurgical outcome for CHD patients
with CD.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Heterotaxy patients have some of the most complex congenital heart disease. Although
surgical advances now allow palliation and repair of even the most complex structural
heart defects, the clinical management of heterotaxy patients remains challenging.
Heterotaxy patients have unexplained higher morbidity and mortality, often with long
clinical courses and increased respiratory complications. Although this higher morbidity
and mortality is usually attributed to the heart disease, the underlying cause remains
largely unknown. Because motile cilia are required both for left-right patterning and for
mucociliary clearance in the airway, we hypothesize that heterotaxy patients may have
risk for airway clearance defects that overlap with that of primary ciliary dyskinesia
(PCD). PCD is a heritable disorder characterized by both laterality defects and also
sinopulmonary disease arising from airway cilia motility defects that compromise mucus
clearance. Using 2 simple tests normally used for PCD assessment, we showed that 42%
of heterotaxy patients with CHD have airway ciliary dysfunction (CD). This included the
observation of abnormal cilia motility by videomicroscopy of nasal scrapes, and also low
nasal nitric oxide (NO) levels similar to the low NO levels seen with PCD. Furthermore,
sequencing analysis showed that heterotaxy patients with CD are significantly enriched
for novel coding variants in genes known to cause PCD. Together these findings suggest
that CHD patients with heterotaxy may benefit from preoperative screening for CD, with
pulmonary therapy to be provided prophylactically to enhance airway clearance in
patients with CD. Such a change in the standard of care may improve outcome and
reduce morbidity/mortality in CHD patients with heterotaxy.
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Laterality and cardiovascular defects in heterotaxy patients. Patients recruited for study; 5
did not complete study. AVC indicates atrioventricular canal; DORV, double outlet right
ventricle; SV, single ventricle; CD, ciliary dysfunction.
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Ciliary motion in nasal epithelia from heterotaxy and PCD patients. A, Abundant cilia
(arrow) were observed in patient 9033 exhibiting normal ciliary motion. B, Paucity of cilia
(arrow) in 9027 with CD. C, No cilia found in nasal epithelia (arrow) of 9004. D, Healthy
control showing normal motion with full forward and recovery strokes (online-only Data
Supplement Movie I). E, PCD patient 9028 has stiff motion with shortened stroke and
minimal ciliary bending. F, Patient 9011 with heterotaxy and CD exhibit shortened forward
stroke and wavy recovery stroke with limited bending of the distal ciliary exoneme (online-
only Data Supplement Movie V). Scale bar=10 μm.
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Nasal nitric oxide measurements in heterotaxy patients. A through C, nNO measurements
from each patient are plotted in 3 age groups. D through F, Box plots show interquartile
range (IQR) from 25 to 75th percentile, with median denoted by bold line. Whiskers denote
minimum-maximum value not >1.5 times the IQR value, with outlying values indicated by
squares. *The nNO values for PCD patients <1 and 1 to 6 years of age were adapted from
Chawla et al.16 CD indicates ciliary dysfunction; PCD, primary ciliary dyskinesia.
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Novel coding variants in PCD genes. More NCVs in PCD genes were observed in
heterotaxy patients with CD and PCD patients than healthy controls. *Probability values
obtained in comparison with controls. Statistical analysis was performed with the Fisher
exact test (A) or the Kruskal-Wallis test followed by Wilcoxon rank sum test (B) with
P<0.025 considered significant based on Bonferroni correction.
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